Its dysregulation contributes to hallmark complications of T1D, including endothelial dysfunction, impaired perfusion, nephropathy, and cardiac vulnerability—thereby identifying TRPV1 as a promising therapeutic target for restoring neurovascular homeostasis. The gene discussed is TRPV1; the disease is Nephropathy.